Veraxa Biotech files Form 3 for Interim CFO Carl von Halem
VRXA•Form 3 filing for interim CFO
- Interim CFO Carl von Halem filed an initial Form 3 for Veraxa Biotech AG, dated July 10, 2026.*
Related News
Real Brokerage plans 10-for-1 share consolidation effective Aug. 24, 2026
REAX•
Hepion Pharmaceuticals names James Liddy to board
HEPA•
Suzano shareholder agreement with Suzano Holding, Grupo Fanny takes effect
SUZ•
New Jersey Resources Corp - Njng Enters Agreement To Sell $150 Million Aggregate Principal Amount Of Senior Notes
NJR•
Evolution Petroleum closes USD 16 million Midland Basin mineral, royalty acquisition
EPM•